Frontiers in Oncology | Neuro-Oncology and Neurosurgical Oncology

Original Research

Published on 23 Sep 2025

XPO1-inhibitor Selinexor induces MGMT expression by activating PKA-CREB signaling in IDH wildtype glioblastoma

in Neuro-Oncology and Neurosurgical Oncology

Josephine A. Mapunda
Yuta Suzuki
Danielle Burgenske
Paul A. Decker
Lin Zhang
Jeanette E. Eckel-Passow
Jann N. Sarkaria
Gaspar J. Kitange

Frontiers in Oncology

doi 10.3389/fonc.2025.1633580

437 views

Original Research

Accepted on 22 Sep 2025

An Implantable, Intracerebral Osmotic Pump for Convection-Enhanced Drug Delivery in Glioblastoma Multiforme

in Neuro-Oncology and Neurosurgical Oncology

Reed Berlet
Azur Azapagic
Neilank K Jha
Daniil Aksenov
Jade Bookwalter
Ata Ullah
George Bobustuc
John Lee
Himanshu Sant
John McDaid

Frontiers in Oncology

doi 10.3389/fonc.2025.1676691

160 views

Systematic Review

Accepted on 22 Sep 2025

A Scientometric Analysis of Global Research on Gut Microbiota and Glioma

in Neuro-Oncology and Neurosurgical Oncology

Lize Chen
Kun Shu
Zhiyin Zhang
Jiao Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1646187

123 views

Case Report

Published on 22 Sep 2025

Case Report: Hypothalamic demyelinating lesion preceding lymphoma arising outside the central nervous system

in Neuro-Oncology and Neurosurgical Oncology

Narushi Sugii
Hiroyoshi Kino
Tetsu Suzuki
Noriaki Sakamoto
Makoto Shibuya
Ken Akimoto
Masahide Matsuda
Eiichi Ishikawa

Frontiers in Oncology

doi 10.3389/fonc.2025.1553142

731 views

Original Research

Published on 22 Sep 2025

Characterization of hypoxia-related molecular clusters and prognostic riskScore for glioma

in Neuro-Oncology and Neurosurgical Oncology

Xiang Fang
Xinhao Wu
Chengran Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1605949

2,061 views

Original Research

Accepted on 18 Sep 2025

Clinical characteristics and analysis of cerebrospinal fluid biochemical, tumor markers and cytologic indices in 209 patients with meningeal carcinomatosis: a cross-sectional study

in Neuro-Oncology and Neurosurgical Oncology

Shaoqiang Xu
Chunxia Huang
Yuangyang Ye
Keyuan Lai
sihan Lan
Zihan Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1594662

543 views

Original Research

Published on 16 Sep 2025

Histopathological grading affects survival in patients with isocitrate dehydrogenase-wildtype gliomas

in Neuro-Oncology and Neurosurgical Oncology

Ziming Hou
Dongyuan Liu
Zhe Hou
Hongbing Zhang
Hao Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1570941

1,933 views

Editorial

Accepted on 11 Sep 2025

Advancing precision therapies in glioblastoma

in Neuro-Oncology and Neurosurgical Oncology

Theophilos Tzaridis
Marike Broekman
Konstantinos Gousias

Frontiers in Oncology

doi 10.3389/fonc.2025.1681786

1,063 views

Review

Published on 11 Sep 2025

Glioma-neuron interactions: insights from neural plasticity

in Neuro-Oncology and Neurosurgical Oncology

Jingyu Feng
Jun Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1661897

1,067 views

Original Research

Published on 11 Sep 2025

GADD45G as a novel prognostic biomarker and therapeutic target in glioma: integrative analysis of bulk and single-cell RNA sequencing

in Neuro-Oncology and Neurosurgical Oncology

Cong Shen
Haiping Cai
Chengliang Mao
Jiahao Yang
Kai Tang

Frontiers in Oncology

doi 10.3389/fonc.2025.1608710

1,003 views

Original Research

Published on 10 Sep 2025

Age is not a significant predictor of survival in patients with IDH-wildtype glioblastoma that undergo gross total resection and complete adjuvant chemoradiation

in Neuro-Oncology and Neurosurgical Oncology

Jeffrey W. Cozzens
Noah B. Drewes
Kristin R. Delfino
Kayla L. Chin
Devin V. Amin
Barbara C. Lokaitis
José A. Espinosa
Breck A. Jones
Leslie J. Acakpo-Satchivi
Hayan Dayoub

Frontiers in Oncology

doi 10.3389/fonc.2025.1657867

774 views

Mini Review

Published on 10 Sep 2025

Significance of ARID1A in neuroblastoma onset mechanism

in Neuro-Oncology and Neurosurgical Oncology

Duo Jin
Dong Zhang
Qinyu Tang

Frontiers in Oncology

doi 10.3389/fonc.2025.1624561

488 views

Systematic Review

Accepted on 08 Sep 2025

Scientometric Analysis of Glioblastoma and Blood-Brain Barrier Research (1995−2024): Evolving Trends and Therapeutic Challenges

in Neuro-Oncology and Neurosurgical Oncology

XuanHao Pan
Nan Wang
YiChun He
Jing Su
Yufei Gao

Frontiers in Oncology

doi 10.3389/fonc.2025.1649414

268 views

Original Research

Published on 03 Sep 2025

MR radiomics in assessment of consistency of pituitary macroadenoma: can T1-weighted contrast enhanced image improve diagnostic performance of T2-weighted image?

in Neuro-Oncology and Neurosurgical Oncology

Menghong Zou
Hongwei Li
Hongchao Yao
Yang Liu
Jie Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1539432

1,386 views

Original Research

Published on 03 Sep 2025

Complex skull base brain tumor resection: the role of microvascular doppler in surgical precision and outcomes

in Neuro-Oncology and Neurosurgical Oncology

Kecheng Shen
Liang Sun
Weiwei Zhai
Lijuan Kong
Jiandong Zhu
Zhengquan Yu
Jiang Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1600980

760 views

Original Research

Published on 02 Sep 2025

Correlation between MGMT methylation and the efficacy of bevacizumab in high-grade glioma

in Neuro-Oncology and Neurosurgical Oncology

Chengrui Yan
Xuexue Bai
Chao Wu
Wenbin Ma
Ming Feng

Frontiers in Oncology

doi 10.3389/fonc.2025.1644934

604 views